| Recruitment status | Completed |
| Unique ID issued by UMIN | UMIN000033821 |
| Receipt No. | R000038576 |
| Official scientific title of the study | Study of effectiveness of on-demand therapy using 20mg vonoprazan for NERD (Grade M by revised LA classification) well controlled with a proton pump inhibitor (PPI) |
| Date of disclosure of the study information | 2018/09/01 |
| Last modified on | 2019/02/19 (Ver. 4) |
| Basic information | ||
| Official scientific title of the study | Study of effectiveness of on-demand therapy using 20mg vonoprazan for NERD (Grade M by revised LA classification) well controlled with a proton pump inhibitor (PPI) | |
| Title of the study (Brief title) | Usefulness of on-demand therapy using 20mg vonoprazan for NERD (Grade M by revised LA classification) | |
| Region |
|
|
| Condition | ||
| Condition | NERD(Grade M by revised LA classification) | |
| Classification by specialty |
|
|
| Classification by malignancy | Others | |
| Genomic information | NO | |
| Objectives | |
| Narrative objectives1 | To clarify the usefulness of on-demand therapy of taking one 20-mg tablet of vonoprazan only when reflux symptoms occurred for patients who have been diagnosed with NERD (LA classification, Grade M), maintain remission by PPI therapy, are satisfied with the treatment and have an esophageal hiatal hernia smaller than 2cm. |
| Basic objectives2 | Efficacy |
| Basic objectives -Others | |
| Trial characteristics_1 | |
| Trial characteristics_2 | |
| Developmental phase | |
| Assessment | |
| Primary outcomes | 1. The overall satisfaction level after 8-week on-demand therapy
2. The gastrin level before breakfast and the number of 20-mg vonoprazan tablets taken before and after on-demand therapy (8 weeks) |
| Key secondary outcomes | |
| Base | |
| Study type | Interventional |
| Study design | |
| Basic design | Single arm |
| Randomization | Non-randomized |
| Randomization unit | |
| Blinding | Open -no one is blinded |
| Control | Uncontrolled |
| Stratification | |
| Dynamic allocation | |
| Institution consideration | |
| Blocking | |
| Concealment | |
| Intervention | ||
| No. of arms | 1 | |
| Purpose of intervention | Treatment | |
| Type of intervention |
|
|
| Interventions/Control_1 | On-demand therapy using 20-mg vonoprazan (8 weeks) | |
| Interventions/Control_2 | ||
| Interventions/Control_3 | ||
| Interventions/Control_4 | ||
| Interventions/Control_5 | ||
| Interventions/Control_6 | ||
| Interventions/Control_7 | ||
| Interventions/Control_8 | ||
| Interventions/Control_9 | ||
| Interventions/Control_10 | ||
| Eligibility | ||||
| Age-lower limit |
|
|||
| Age-upper limit |
|
|||
| Gender | Male and Female | |||
| Key inclusion criteria | 1. Over 20 years old and younger than 80 years old
2. Both males and females 3. Outpatients 4. Patients who have been diagnosed with NERD (LA classification, Grade M), maintain remission by standard-dose PPI therapy, and satisfied with the treatment, and have an esophageal hiatal hernia smaller than 2cm 5. Patients who understood study, and provided written consent based on their own will |
|||
| Key exclusion criteria | 1. Allergy patients to drugs being studied
2. Patients with critical dysfunction of liver and kidney 3. Patients with malignancy 4.Patints suspected with active infection 5. Pregnant or possibility of being pregnant, and those who are breastfeeding 6. Study participation decided to be contraindicated by the parson in charge |
|||
| Target sample size | 30 | |||
| Research contact person | |
| Name of lead principal investigator | Katsuhiko Iwakiri |
| Organization | Nippon Medical School |
| Division name | Department of Gastroenterology |
| Address | 1-1-5 Sendagi, Bunkyo-ku, Tokyo |
| TEL | 03-3822-2131 |
| k-iwa@nms.ac.jp | |
| Public contact | |
| Name of contact person | Katsuhiko Iwakiri |
| Organization | Nippon Medical School |
| Division name | Department of Gastroenterology |
| Address | 1-1-5, Sendagi, Bunkyo-ku, Tokyo |
| TEL | 03-3822-2131 |
| Homepage URL | |
| k-iwa@nms.ac.jp | |
| Sponsor | |
| Institute | Nippon Medical School Hospital |
| Institute | |
| Department | |
| Funding Source | |
| Organization | None |
| Organization | |
| Division | |
| Category of Funding Organization | Self funding |
| Nationality of Funding Organization | |
| Other related organizations | |
| Co-sponsor | |
| Name of secondary funder(s) | |
| Secondary IDs | |
| Secondary IDs | NO |
| Study ID_1 | |
| Org. issuing International ID_1 | |
| Study ID_2 | |
| Org. issuing International ID_2 | |
| IND to MHLW | |
| Institutions | |
| Institutions | |
| Other administrative information | |||||||
| Date of disclosure of the study information |
|
||||||
| Progress | |||||||
| Recruitment status | Completed | ||||||
| Date of protocol fixation |
|
||||||
| Anticipated trial start date |
|
||||||
| Last follow-up date | |||||||
| Date of closure to data entry | |||||||
| Date trial data considered complete | |||||||
| Date analysis concluded | |||||||
| Related information | |
| URL releasing protocol | |
| Publication of results | Published |
| URL releasing results | |
| Results | |
| Other related information | |
| Management information | |||||||
| Registered date |
|
||||||
| Last modified on |
|
||||||
| Link to view the page | |
| URL(English) | https://upload.umin.ac.jp/cgi-open-bin/icdr_e/ctr_view.cgi?recptno=R000038576 |